Yep - the 4C didnt impress me either! I know this is a standard inquiry by the ASX - but it would have been better if the answers were already given rather than the ASX having to chase them down.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025